Characteristics | -1830 T > C | -1003G > A | -115G > A | ||||||
---|---|---|---|---|---|---|---|---|---|
TT | CT,CC | P | GG | GA,AA | P | GG | GA,AA | P | |
n = 238 (79.3%) | n = 62 (20.7%) | value | n = 250 (83.3%) | n = 50 (6.7%) | value | n = 235 (78.3%) | n = 65 (21.7%) | value | |
Oral ulcera | 122 (51.3%) | 26 (41.9%) | 0.191 | 130 (52.0%) | 18 (36.0%) | 0.039 | 124 (52.8%) | 24 (36.9%) | 0.024 |
Arthritisa | 151 (63.4%) | 51 (82.3%) | 0.005 | 160 (64.0%) | 42 (84.0%) | 0.006 | 146 (62.1%) | 56 (86.2%) | <0.001 |
Anti-ds DNAa | 156 (65.5%) | 47 (75.8%) | 0.124 | 163 (65.2%) | 40 (80.0%) | 0.041 | 153 (65.1%) | 50 (76.9%) | 0.071 |
CNS involvementa | 19 (8.0%) | 3 (4.8%) | 0.295 | 22 (8.8%) | 0 (0.0%) | 0.015 | 20 (8.5%) | 2 (3.1%) | 0.106 |
Triglycerideb | 97.8 ± 64.1 | 112.8 ± 67.1 | 0.108 | 95.6 ± 61.5 | 126.9 ± 74.9 | 0.007 | 95.3 ± 62.1 | 120.9 ± 71.2 | 0.011 |
Characteristics | HT1 [TTGG] | HT2 [CTGG] | HT3 [TCGG] | ||||||
+/+ | +/-, -/- | P | +/+ | +/-, -/- | P | +/+, +/- | -/- | P | |
n = 63 (41.7%) | n = 88 (58.3%) | value | n = 24 (15.9%) | n = 127 (84.1%) | value | n = 30 (19.8%) | n = 121 (80.1%) | value | |
Arthritisa | 62 (56.9%) | 140 (73.3%) | 0.004 | 9 (56.3%) | 193 (68.0%) | 0.331 | 29 (90.6%) | 173 (64.6%) | 0.003 |
Leukopeniaa | 61 (56.0%) | 112 (58.6%) | 0.652 | 11 (68.8%) | 162 (57.0%) | 0.356 | 20 (62.5%) | 153 (57.1%) | 0.558 |
Lymphopeniaa | 100 (91.7%) | 172 (90.1%) | 0.628 | 12 (75.0%) | 260 (91.5%) | 0.027 | 30 (93.8%) | 242 (90.3%) | 0.526 |